Kunle Odunsi named SITC board member

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Kunle Odunsi, deputy director of Roswell Park Comprehensive Cancer Center, was named an at-large director of the Society for Immunotherapy of Cancer Board of Directors.

The organization’s members voted for Odunsi during their election in May. He will begin his three-year term in January 2021.

Odunsi is also the Robert, Anne & Lew Wallace Endowed Chair in Cancer Immunotherapy, executive director of the Center for Immunotherapy and M. Steven Piver Endowed Professor and chair of the Department of Gynecologic Oncology at Roswell Park.

A fellow of both the Royal College of Obstetricians and Gynaecologists in the United Kingdom and the American College of Obstetricians and Gynecologists, he holds lifetime membership in the National Academy of Medicine.

Table of Contents

YOU MAY BE INTERESTED IN

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.

Login